LRRK2 and Parkinson disease: A recent report has shown that higher levels of peripheral inflammatory cytokines were found in the sera of both asymptomatic LRRK2 G2019S carriers and PD patients carrying LRRK2 G2019S [46], suggesting pathological contributions from LRRK2 mutations within peripheral immune cells.